Daily SPAC Update – Feb 23, 2024

by | Feb 23, 2024

Lotus Technology / LCAA DeSPACs as LOT. MACA + Silexion Therapeutics. FICV Shareholders Approve Liquidation.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

DeSPACs
LCAA -> LOT on Feb 23

SPAC DEALS ANNOUNCED
MACA + Silexion Therapeutics

SPACC VOTE RESULTS
FICV – FRONTIER INVESTMENT CORP * To Liquidate / Shareholders Approve * trust $10.75
GIA – GIGCAPITAL5 INC * Deal Approved

OTHER SPAC NEWS
TGVC – TG VENTURE ACQUISITION CORP * Delayed vote to March 1 * trust $11.20
KWAC – KINGSWOOD ACQUISITION CORP * Extend * March 15

YESTERDAY’S TOP SPAC GAINERS
31.06% ~ $ 12.32 | SEPA – SEP ACQUISITION CORP (Announced)
8.16% ~ $ 46.68 | DWAC – Digital World Acquisition Corp. (Announced)
7.89% ~ $ 10.25 | APAC – StoneBridge Acquisition Corp. (Announced)
5.76% ~ $ 4.96 | DECA – Denali Capital Acquisition Corp. (Announced)
5.65% ~ $ 11.40 | TGVC – TG Venture Acquisition Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-13.78% ~ $ 8.01 | WNNR – Andretti Acquisition Corp. (Announced)
-9.56% ~ $ 5.96 | LBBB – Lakeshore Acquisition II Corp. (Announced)
-8.74% ~ $ 9.40 | OXUS – Oxus Acquisition Corp. (Announced)
-6.07% ~ $ 10.99 | MBTC – Nocturne Acquisition Corporation (Announced)
-6.06% ~ $ 11.16 | SZZL – Sizzle Acquisition Corp. (Announced)

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.